HomeNewsIndiaCOVID-19: List of states that will not begin vaccination drive for 18-44 age group from May 1

COVID-19: List of states that will not begin vaccination drive for 18-44 age group from May 1

Several states like Maharashtra, Punjab, Gujarat and Andhra Pradesh said they do not have sufficient doses to vaccinate those in the 18-44 age group. Here is the full list:

April 30, 2021 / 18:42 IST
Story continues below Advertisement
Registration for the people in the 18-44 age group began on April 29.
Registration for the people in the 18-44 age group began on April 29.

Several states have said they don't have enough jabs to begin vaccinating people in the 18-44 age group in Phase 3 of the nationwide COVID-19 vaccination drive that is to kick in from May 1.

The Union health ministry, however, has denied any shortage of coronavirus vaccine in India. On April 29, it said that more than 1 crore doses are still available with states and UTs and they will receive over 20 lakh more doses within the next three days.

Story continues below Advertisement

As the second wave of coronavirus rips through the country, efforts have been stepped up to inoculate as many people as possible but the availability of vaccines has pitted the states against the Centre.

India has approved three vaccines for emergency use. While Covishield, which is the local name for the Oxford University-AstraZeneca jab manufactured by the Serum Institute of India, and Bharat Biotech made Covaxin are in use, Russia’s Sputnik V is expected to be available in the coming weeks.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show